CIPLA's weekly performance was disappointing, with a return of -2.58% and a Sharpe Ratio of -0.85, indicating poor risk-adjusted returns. The stock's volatility was moderate at 16.23%, but its max drawdown was also -2.58%, suggesting a relatively high level of risk. Compared to its peers, CIPLA underperformed SUNPHARMA and DIVISLAB, but was outperformed by GRASIM. Overall, CIPLA was a relatively risky investment this week.

[Volatility: 16.23%]